In addition, there were no significant differences observed in administration of other cancer therapeutic agents (e.g., platinum, and vascular endothelial growth factor signaling pathways inhibitor agents) within 1 month before the AKI diagnosis. Here, VEGFA is linked to acute kidney injury.